跳至主要内容
临床试验/NCT05920122
NCT05920122已完成4 期

A Randomized Control Trial of Chlorhexidine Gluconate Aqueous Solution vs Chlorhexidine Gluconate With Isopropyl Alcohol Skin Preparations for Prevention of Cesarean Section Wound Infections

Hyagriv Simhan1 个研究点 分布在 1 个国家目标入组 1,398 人开始时间: 2023年10月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1,398
试验地点
1
主要终点
Number of Participants with Surgical site Infection

研究概览

简要总结

This will be a single-center randomized control trial comparing the efficacy of two different formulations of Chlorhexidine surgical skin preparation in preventing cesarean section wound infections. Participants will be randomized to either 4% Chlorhexidine Gluconate aqueous solution (CHG) or 2% Chlorhexidine with isopropyl alcohol (CHG-IPA) 70% to examine the risk of infectious morbidity in those undergoing cesarean delivery. There will also be a cost-effectiveness analysis of the two preoperative skin preparations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

The provider making the diagnosis of wound infection will be blinded to the intervention

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women undergoing cesarean delivery at Magee Women's Hospital

排除标准

  • Inability to obtain consent (language barrier, emergency cesarean section etc.)
  • Allergy to chlorhexidine or alcohol
  • Chorioamnionitis
  • Emergency cesareans where cannot wait for chlorhexidine alcohol to dry
  • bowel injury at time of cesarean section
  • Women who are delivered at another institution and are transferred postpartum to Magees Women's Hospital

研究组 & 干预措施

2% Chlorhexidine gluconate with 70% alcohol (ChloraPrep)

Experimental

Including cases undergoing elective &non elective caesarean section. Patients will be prepared similarly using the appropriate number of 26mL Chloraprep sticks for their body surface area. The lever will be pinched to activate the ampoule and release the antiseptic. The solution will be given time to partially load in the sponge. The sponge will be pressed against the skin area where the incision is intended moving back and forth for 30 sec , then working up towards the upper edge of the surgical field and then working from below the incision sight to the upper thighs. The antiseptic will be given time to dry (3 min)

干预措施: 2% Chlorhexidine gluconate with 70% alcohol (Drug)

4% chlorhexidine gluconate (Hibiclens)

Experimental

Including cases undergoing elective & nonelective caesarean section. Patients will be scrubbed preoperative with an applicator that contain 4% chlorohexidine aqueous solution (3 consecutive applications) liberally over 2 minutes followed by drying with sterile towel. The area scrubbed will be the same as the chloraprep group.

干预措施: 4% Chlorhexidine Gluconate aqueous solution (Drug)

结局指标

主要结局

Number of Participants with Surgical site Infection

时间窗: Within 30 days post cesarean

Superficial or deep surgical-site infection within 30 days after cesarean delivery, on the basis of the National Healthcare Safety Network definitions of the Centers for Disease Control and Prevention.

次要结局

  • Number of participants with hematoma(Within 90 days post cesarean)
  • The type of bacterial species isolated from wound infection cultures(Within 90 days post cesarean)
  • Length of Hospital Stay(Within 90 days post cesarean)
  • Number of Participants who needed wound vacuum(Within 90 days post cesarean)
  • Number of Participants who needed home health(Within 90 days post cesarean)
  • Number of doses of antibiotic treatment(Within 90 days post cesarean)
  • Number of participants with positive culture from wound(Within 90 days post cesarean)
  • Number of Participants with intrabdominal/pelvic abscess(Within 90 days post cesarean)
  • Number of Participants With Endometritis(Within 30 days post cesarean)
  • Number of Participants with necrotizing fasciitis(Within 90 days post cesarean)
  • Number of Participants with sepsis(Within 90 days post cesarean)
  • Number of Participants with Need for wound opening, exploration, or washout in the operating room(Within 90 days post cesarean)
  • Number of Participants With Re-admissions or Office Visits for Wound-related Problems(Within 90 days post cesarean)
  • Number of Participants with ICU admission for wound infectious complications(Within 90 days post cesarean)
  • Number of patients who needed antibiotics(Within 90 days post cesarean)
  • Antibiotic regimens (medication names) used to treat infection(Within 90 days post cesarean)
  • Number of participants with seroma(Within 30 days post cesarean)
  • Number of Participants With Skin Irritation(within 48 hours from delivery)
  • Number of Participants With Allergic Reaction(within 48 hours from delivery)
  • Cost Savings(Within 90 days post cesarean)

研究者

发起方
Hyagriv Simhan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hyagriv Simhan

Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验